The Antifungal Drugs Market Report is a fusion of competitive scenarios and key trends affecting industry growth in areas of a successful business. In addition, a comprehensive survey of industry changes caused by the COVID-19 pandemic is also tagged in the report, helping investors and other participants make informed decisions. The report consists of a detailed study of potential segments, including product types, applications, end-users, and contributions to overall market size.
These various types of antifungals are available for the treatment of fungal infections. An antifungal drug, clotrimazole, is available in various types. The various types are available in tablet, liquid, suppository, and gels. Capsules are particularly effective, as they are larger and last longer. Most of the antifungals are available without a prescription in most parts of the United States.
Top Key Players:
Major players operating in the antifungal drugs market include, Novartis AG, Pfizer, Inc., Sanofi, Merck, Enzon Pharmaceuticals, Bayer AG, Astellas Pharma, GlaxoSmithKline, Abbott Laboratories, J & J, Teva, and Mylan
“We provide a sample of this report. Please see the following link to access the sample page containing TOC, key profiles, tables, and diagrams.”
Request a sample report: https://www.stratagemmarketinsights.com/sample/25569
Market Dynamics:
High prevalence of fungal infections is expected to propel growth of the antifungal drugs market over the forecast period. For instance, annually, over 150 million severe cases of fungal infections occur worldwide, resulting in approximately 1.7 million deaths per year.
Emergence of Covid-19 is also expected to aid in growth of the antifungal drugs market. Globally, as of 5:09 pm CEST, 20 October 2021, there have been 241,411,380 confirmed cases of COVID-19, including 4,912,112 deaths, reported to WHO. As of 19 October 2021, a total of 6,545,309,084 vaccine doses have been administered. In April 2021, research published in the British Journal of Pharmacology reported that antifungal itraconazole and the antidepressant fluoxetine can effectively inhibit the virus that causes COVID-19 in laboratory cells.
Inclusion of antifungal drugs in lists of essential medicines is expected to offer lucrative growth opportunities for players in the antifungal drugs market. For instance, in October 2021, The World Health Organization included new drugs for treatments of cancer and diabetes, antimicrobials, antifungal drugs and tobacco cessation medicines in the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children.
Major players operating in the antifungal drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in September 2021, SCYNEXIS, Inc. announced the availability of BREXAFEMME (ibrexafungerp tablets), an oral non-azole antifungal medication in the U.S for the treatment of vulvovaginal candidiasis.
Key Takeaways:
- High prevalence of fungal infections is expected to propel growth of the antifungal drugs market over the forecast period
- Major players operating in the antifungal drugs market are focused on approval and launch of new products to expand their product portfolio. For instance, in October 2021, Intas Pharmaceuticals Limited launched Super Bioavailable Itraconazole-SB 100mg, an antifungal drug, under the brand name – Itaspor-SB Forte/Subawin.
Need customization? Enter your requirements here: https://www.stratagemmarketinsights.com/quiry/25569
The report covers segment analysis:
Based on Type, the Antifungal Drugs market is segmented:
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
Based on the Application, the Antifungal Drugs market is divided
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
Benefits of purchasing the Antifungal Drugs Market Report:
Some of the key factors that companies are interested in have been specifically identified and studied. For example, market segmentation, revenue, Covid-19 impact, predictive analytics, key players, regional analytics, product types and applications, new innovation strategies and product introductions, and many other factors contribute to market growth. It is mentioned. Therefore, this report serves as a useful blueprint for your business.
We will highlight certain regions that hold higher profits compared to other regions and explain why they are responsible for this advantage.
The Antifungal Drugs research report also describes the various drivers, opportunities, and constraints of the market. It also provides market-wide relevant information by assessing various factors to provide SWOT & PESTEL analysis. Overall information covering all market factors, aspects, scenarios, and situations in global standards can be found in the research report.
Main reasons to buy:
Gain a comprehensive understanding of the Global Antifungal Drugs Market Industry Analysis and Forecast 2021-2028 and its commercial outlook with market insightful analysis. Learn about market strategies adopted by competitors and major organizations. Antifungal Drugs Market Industry Analysis and Forecast Understand the future outlook and outlook for 2021-2028.
Purchase This Report with up to 40% Discount (Single User License Price 3000 USD) @ https://www.stratagemmarketinsights.com/cart/25569
Main points in Antifungal Drugs Market Report Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Antifungal Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Antifungal Drugs Industry Impact
Chapter 2 Antifungal Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Antifungal Drugs (Volume and Value) by Type
2.3 Antifungal Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Antifungal Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Antifungal Drugs Market Analysis
Chapter 6 East Asia Antifungal Drugs Market Analysis
Chapter 7 Europe Antifungal Drugs Market Analysis
Chapter 8 South Asia Antifungal Drugs Market Analysis
Chapter 9 Southeast Asia Antifungal Drugs Market Analysis
Chapter 10 Middle East Antifungal Drugs Market Analysis
Chapter 11 Africa Antifungal Drugs Market Analysis
Chapter 12 Oceania Antifungal Drugs Market Analysis
Chapter 13 South America Antifungal Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Antifungal Drugs Business
Chapter 15 Antifungal Drugs Market Forecast (2021-2028)
Chapter 16 Conclusions
Research Methodology
Continued………….
Who We Are:
Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. We strive to offer sapient solutions, expert consultations, and tailored/customized solutions. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports. The domain-specific teams are constantly focused on tracking markets, aiding our clients to gain a competitive edge through high-quality market intelligence. We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management.
Contact Us:
Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737
Email: sales@stratagemmarketinsights.com